Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GE HealthCare Technologies Inc. - Common Stock
(NQ:
GEHC
)
82.44
+0.44 (+0.54%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about GE HealthCare Technologies Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
November 22, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
November 21, 2024
From
GE HealthCare
Via
Business Wire
Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue
November 18, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
November 13, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage
November 12, 2024
From
GE HealthCare
Via
Business Wire
How AI is Shaping the Future of Healthcare: Key Advances in Diagnostics and Precision Medicine
November 12, 2024
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:BFLY),(NASDAQ:TEM),(NASDAQ:GEHC),(NASDAQ:RDNT) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
November 11, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
November 07, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares
November 07, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare to Host its 2024 Investor Day on November 21
November 07, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare reports third quarter 2024 financial results
October 30, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare Announces AI Innovation Lab Showcasing Five New Research Projects
October 21, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare announces CareIntellect for Oncology, harnessing AI to give clinicians an easy way to see the patient journey in a single view
October 21, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare, the GE HealthCare Foundation, and the Charles Antetokounmpo Family Foundation commit $1M to improve Milwaukee health outcomes
October 18, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare announces major academic medical center as first customer to adopt new Hospital Pulse Tile for Command Center
October 17, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
A New Theranostics Center of Excellence in Europe: GE HealthCare and University Medicine Essen Collaborate to Advance Theranostics and Personalized Medicine
October 16, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare introduces easy-to-use, easy-to-learn, easy-to-diagnose Versana Premier multi-purpose ultrasound system
October 14, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare Accelerates Artificial Intelligence Adoption With New Offering to Advance Enterprise Imaging
October 09, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare to announce third quarter 2024 results on October 30, 2024
October 08, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare takes key role in new consortium to revolutionize cancer care, advancing precision medicine for patients in Europe
October 07, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent
October 07, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease
September 27, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024
September 26, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
September 19, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare announces cash dividend for third quarter of 2024
September 18, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares
September 12, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares
September 12, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024
August 26, 2024
From
GE HealthCare
Via
Business Wire
GE HealthCare management to present at September investor conferences
August 21, 2024
From
GE HealthCare Technologies Inc.
Via
Business Wire
Clinical Study Shows Targeted End-tidal Control Anesthesia Delivery Improves Efficiency and Accuracy to Help Optimize Patient Care
August 20, 2024
From
GE HealthCare
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.